NEW YORK, Dec. 15 Reportlinker.com announces that a new market research report is available in its catalogue:
The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
Advertisement
http://www.reportlinker.com/p0168100/The-Future-of-Autoimmune-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html
Advertisement
Summary
The author has released its latest research "The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis" The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global autoimmune diseases therapeutics market. The report analyzes the markets for autoimmune disease therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2015 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.
Scope
The scope of this report includes:
- Annualized market data for the autoimmune diseases therapeutics market from 2000 to 2008, forecast forward to 2015
- Analysis of the leading therapeutic segments including rheumatoid arthritis, multiple sclerosis, systemic lupus, erythematosus, crohn's disease and ulcerative colitis
- Analysis of the autoimmune diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
- Market characterization of the autoimmune diseases therapeutics market including market size, annual cost of therapy, sales volume and treatment usage patterns
- Key drivers and barriers that have a significant impact on the market
- Coverage of pipeline molecules in various phases of drug development
- Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche, Novartis AG, Sanofi-aventis, Amgen Inc, AstraZeneca, Merck & Co, Pfizer Inc, Celgene Corporation, Bristol-Myers Squibb and Eli Lilly
- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global autoimmune diseases therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to
- Align product portfolio to the markets with high growth potential
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
- Develop key strategic initiatives by understanding key focus areas of leading companies
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction To the Global Autoimmune Disease Therapeutics Market
2.1 Introduction
2.2 GBI Research Report Guidance
3 Global Autoimmune Disease Therapeutics Market: Market Characterization
3.1 Market Overview
3.2 Market Forecasts
3.3 Branded Versus Generics
3.4 Market Share by Disease Sectors
3.5 Average Cost of Therapy
3.6 Volume
3.7 Usage Patterns
3.7.1 Diseased Population
3.7.2 Treatment Seeking Population
3.7.3 Diagnosis Population
3.7.4 Prescription Population
3.7.5 Therapeutics Usage Patterns
3.8 Geographical Distribution
3.9 Drivers and Restraints
3.9.1 Market Drivers
3.9.2 Market Restraints
3.10 Unmet Needs
3.11 Key Market Trends
3.11.1 Growing Patient Population and Medical Proclivity for Long Term Treatments
3.11.2 High levels of Unmet Need
3.11.3 Increasing Acceptance of Biologics for Autoimmune Disease Treatment
3.11.4 Increase in Drug Label Extension Over the Forecast Period
3.11.5 Increase in Strategic Consolidation Within the Autoimmune Disease Therapeutics Market
4 Global Rheumatoid Arthritis Therapeutics Market
4.1 Market Overview
4.2 Market Forecasts
4.3 Average Cost of Therapy
4.4 Volume
4.5 Usage Patterns
4.5.1 Diseased Population
4.5.2 Treatment Seeking Population
4.5.3 Diagnosis Population
4.5.4 Prescription Population
4.5.5 Therapeutic Usage Patterns
4.6 Product Analysis
4.6.1 Orencia
4.6.2 Voltaren/Cataflam
4.6.3 Enbrel
4.6.4 Remicade
4.6.5 Humira
4.6.6 Rituxan
4.6.7 Prograf
4.6.8 Rheumatrex
4.6.9 Celebrex
4.6.10 Arava
4.7 Drug Pipeline Analysis
5 Global Systemic Lupus Erythematosus Therapeutics Market
5.1 Market Overview
5.2 Market Forecasts
5.3 Average Cost of Therapy
5.4 Volume
5.5 Usage Patterns
5.5.1 Diseased Population
5.5.2 Treatment Seeking Population
5.5.3 Diagnosis Population
5.5.4 Prescription Population
5.5.5 Therapeutic Usage Patterns
5.6 Product Analysis
5.6.1 CellCept
5.6.2 Medrol/Depo-Medrol
5.6.3 Plaquenil
5.6.4 Imuran
5.6.5 Azasan
5.6.6 Cyclophosphamide
5.6.7 Rituximab
5.7 Drug Pipeline Analysis
6 Global Multiple Sclerosis Therapeutics Market
6.1 Market Overview
6.2 Market Forecasts
6.3 Average Cost of Therapy
6.4 Volume
6.5 Usage Patterns
6.5.1 Diseased Population
6.5.2 Treatment Seeking Population
6.5.3 Diagnosis Population
6.5.4 Prescription Population
6.5.5 Therapeutic Usage Patterns
6.6 Product Analysis
6.6.1 Avonex
6.6.2 Acthar
6.6.3 Betaferon/Betaseron
6.6.4 Copaxone
6.6.5 Rebif
6.6.6 Tysabri
6.7 Drug Pipeline Analysis
7 Global Psoriasis Therapeutics Market
7.1 Market Overview
7.2 Market Forecasts
7.3 Average Cost of Therapy
7.4 Volume
7.5 Usage Patterns
7.5.1 Diseased Population
7.5.2 Treatment Seeking Population
7.5.3 Diagnosis Population
7.5.4 Prescription Population
7.5.5 Therapeutic Usage Patterns
7.6 Product Analysis
7.6.1 Amevive
7.6.2 Dovonex
7.6.3 Enbrel
7.6.4 Fumaderm
7.6.5 Humira
7.6.6 Neoral
7.6.7 Raptiva
7.6.8 Remicade
7.6.9 Tazorac
7.7 Drug Pipeline Analysis
8 Global Crohn's Disease Therapeutics Market
8.1 Market Overview
8.2 Market Forecasts
8.3 Average Cost of Therapy
8.4 Volume
8.5 Usage Patterns
8.5.1 Diseased Population
8.5.2 Treatment Seeking Population
8.5.3 Diagnosis Population
8.5.4 Prescription Population
8.5.5 Therapeutics Usage Patterns
8.6 Product Analysis
8.6.1 Asacol
8.6.2 Cimzia
8.6.3 Entocort EC
8.6.4 Humira
8.6.5 Remicade
8.7 Drug Pipeline Analysis
9 Global Ulcerative Colitis Therapeutics Market
9.1 Market Overview
9.2 Market Forecasts
9.3 Average Cost of Therapy
9.4 Volume
9.5 Usage Patterns
9.5.1 Diseased Population
9.5.2 Treatment Seeking Population
9.5.3 Diagnosis Population
9.5.4 Prescription Population
9.5.5 Therapeutic Usage Patterns
9.6 Product Analysis
9.6.1 Asacol
9.6.2 Apriso
9.7 Drug Pipeline Analysis
10 Global Autoimmune Disease Therapeutics Market: The US Market
10.1 Market Overview
10.2 Market Forecasts
10.3 Average Cost of Therapy
10.4 Volume
10.5 Usage Patterns
10.5.1 Diseased Population
10.5.2 Treatment Seeking Population
10.5.3 Diagnosis Population
10.5.4 Prescription Population
10.5.5 Therapeutic Usage Patterns
11 Global Autoimmune Disease Therapeutics Market: The European Market
11.1 Market Overview
11.2 Market Forecasts
11.3 Average Cost of Therapy
11.4 Volume
11.5 Usage Patterns
11.5.1 Diseased Population
11.5.2 Treatment Seeking Population
11.5.3 Diagnosis Population
11.5.4 Prescription Population
11.5.5 Therapeutic Usage Patterns
12 Global Autoimmune Disease Therapeutics Market: The Japanese Market
12.1 Market Overview
12.2 Market Forecasts
12.3 Average Cost of Therapy
12.4 Volume
12.5 Usage Patterns
12.5.1 Diseased Population
12.5.2 Treatment Seeking Population
12.5.3 Diagnosis Population
12.5.4 Prescription Population
12.5.5 Therapeutic Usage Patterns
13 Global Autoimmune Disease Therapeutics Market: Competitive Landscape
13.1 Overview
13.2 Competitive Profiling
13.2.1 Amgen
13.2.2 Bristol-Myers Squibb
13.2.3 Novartis
13.2.4 Pfizer
13.2.5 Bayer AG
13.2.6 Biogen Idec.
13.2.7 Roche
13.2.8 Sanofi-aventis
13.2.9 Johnson & Johnson
13.2.10 Shire Pharmaceuticals
13.2.11 UCB Pharma
13.2.12 Salix Pharmaceuticals
13.2.13 Abbott Pharmaceuticals
13.2.14 Takeda Pharmaceutical
13.2.15 Teva Pharmaceuticals
13.2.16 Santen Pharma
13.2.17 Warner Chilcott
13.2.18 Roxane labs
13.2.19 Questcor Pharmaceutical
13.2.20 Procter & Gamble Pharmaceuticals
13.2.21 Merck Serono
13.2.22 Forest Laboratories
13.2.23 Allergan Pharmaceuticals
13.2.24 Astellas Pharma Inc.
13.2.25 King Pharmaceuticals
13.2.26 Prometheus Labs
14 Global Autoimmune Disease Therapeutics Market: Strategic Consolidations
14.1 Mergers and Acquisitions (M&A)
14.1.1 Cephalon, Inc. Acquired Arana Therapeutics Limited
14.1.2 Johnson & Johnson Acquired Elan Corporation plc
14.1.3 Bayer Healthcare acquired Genzyme Corp.
14.1.4 Paladin Labs Inc. acquired ViRexx Medical Corp.
14.2 Licensing Agreements
14.2.1 Overview
14.2.2 Discovery and Preclinical
14.2.3 Phase I
14.2.4 Phase II
14.2.5 Phase III
14.2.6 Approved
15 Appendix
15.1 Market Definitions
15.2 Abbreviations
15.3 Research Methodology
15.3.1 Coverage
15.3.2 Secondary Research
15.3.3 Primary Research
15.3.4 Forecasts
15.3.5 Expert Panel Validation
15.4 Contact Us
15.5 Disclaimer
1.1 List of Tables
Table 1: Autoimmune Disease Therapeutics Market, Global, Revenue Forecasts ($mn), 2000-2008
Table 2: Autoimmune Disease Therapeutics Market, Global, Revenue Forecasts ($mn), 2008-2015
Table 3: Autoimmune Disease Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2008
Table 4: Autoimmune Disease Therapeutics Market, Global, Average Cost of Therapy ($), 2008-2015
Table 5: Autoimmune Disease Therapeutics Market, Global, Volume, 2000-2008
Table 6: Autoimmune Disease Therapeutics Market, Global, Volume, 2008-2015
Table 7: Autoimmune Disease Therapeutics Market, Global, Diseased Population, 2000-2008
Table 8: Autoimmune Disease Therapeutics Market, Global, Diseased Population, 2008-2015
Table 9: Autoimmune Disease Therapeutics Market, Global, Treatment Seeking Population, 2000-2008
Table 10: Autoimmune Disease Therapeutics Market, Global, Treatment Seeking Population, 2008-2015
Table 11: Autoimmune Disease Therapeutics Market, Global, Diagnosis Population, 2000-2008
Table 12: Autoimmune Disease Therapeutics Market, Global, Diagnosis Population, 2008-2015
Table 13: Autoimmune Disease Therapeutics Market, Global, Prescription Population, 2000-2008
Table 14: Autoimmune Disease Therapeutics Market, Global, Prescription Population, 2008-2015
Table 15: Autoimmune Disease Therapeutics Market, Global, Therapeutic Usage Patterns, 2000-2008
Table 16: Autoimmune Disease Therapeutics Market, Global, Therapeutic Usage Patterns, 2008-2015
Table 17: Autoimmune Disease Therapeutics Market, Global, Market Drivers, 2008
Table 18: Autoimmune Disease Therapeutics Market, Global, Market Restraints, 2008
Table 19: Rheumatoid Arthritis Therapeutics Market, Global, Revenue Forecasts ($mn), 2000-2008
Table 20: Rheumatoid Arthritis Therapeutics Market, Global, Revenue Forecast ($mn), 2008-2015
Table 21: Rheumatoid Arthritis Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2008
Table 22: Rheumatoid Arthritis Therapeutics Market, Global, Average Cost of Therapy ($), 2008-2015
Table 23: Rheumatoid Arthritis Therapeutics Markets, Global, Volume, 2000-2008
Table 24: Rheumatoid Arthritis Therapeutics Market, Global, Volume, 2008-2015
Table 25: Rheumatoid Arthritis Therapeutics Market, Global, Diseased Population, 2000-2008
Table 26: Rheumatoid Arthritis Therapeutics Market, Global, Diseased Population, 2008-2015
Table 27: Rheumatoid Arthritis Therapeutics Market, Global, Treatment Seeking Population, 2000-2008
Table 28: Rheumatoid Arthritis Therapeutics Market, Global, Treatment Seeking Population, 2008-2015
Table 29: Rheumatoid Arthritis Therapeutics Market, Global, Diagnosis Population, 2000-2008
Table 30: Rheumatoid Arthritis Therapeutics Market, Global, Diagnosis Population, 2008-2015
Table 31: Rheumatoid Arthritis Therapeutics Market, Global, Prescription Population, 2000-2008
Table 32: Rheumatoid Arthritis Therapeutics Market, Global, Prescription Population, 2008-2015
Table 33: Rheumatoid Arthritis Therapeutics Market, Global, Therapeutic Usage Patterns, 2000-2008
Table 34: Rheumatoid Arthritis Therapeutics Market, Global, Therapeutic Usage Patterns, 2008-2015
Table 35: Rheumatoid Arthritis Therapeutics Market, Global, Major Manufacturers and Drugs, 2008
Table 36: Systemic Lupus Erythematosus Therapeutics Market, Global, Revenue Forecasts ($mn), 2000-2008
Table 37: Systemic Lupus Erythematosus Therapeutics Market, Global, Revenue Forecasts ($mn), 2008-2015
Table 38: Systemic Lupus Erythematosus Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2008
Table 39: Systemic Lupus Erythematosus Therapeutics Market, Global, Average Cost of Therapy ($), 2008-2015
Table 40: Systemic Lupus Erythematosus Therapeutics Market, Global, Volume, 2000-2008
Table 41: Systemic Lupus Erythematosus Therapeutics Market, Global, Volume, 2008-2015
Table 42: Systemic Lupus Erythematosus Therapeutics Market, Global, Diseased Population, 2000-2008
Table 43: Systemic Lupus Erythematosus Therapeutics Market, Global, Diseased Population, 2008-2015
Table 44: Systemic Lupus Erythematosus Therapeutics Market, Global, Treatment Seeking Population, 2000-2008
Table 45: Systemic Lupus Erythematosus Therapeutics Market, Global, Treatment Seeking Population, 2008-2015
Table 46: Systemic Lupus Erythematosus Therapeutics Market, Global, Diagnosis Population, 2000-2008
Table 47: Systemic Lupus Erythematosus Therapeutics Market, Global, Diagnosis Population, 2008-2015
Table 48: Systemic Lupus Erythematosus Therapeutics Market, Global, Prescription Population, 2000-2008
Table 49: Systemic Lupus Erythematosus Therapeutics Market, Global, Prescription Population, 2008-2015
Table 50: Systemic Lupus Erythematosus Therapeutics Market, Global, Therapeutic Usage Patterns, 2000-2008
Table 51: Systemic Lupus Erythematosus Therapeutics Market, Global, Therapeutics Usage Patterns, 2008-2015
Table 52: Rheumatoid Arthritis Therapeutics Market, Global, Major Manufacturers and Drugs, 2008
Table 53: Multiple Sclerosis Therapeutics Market, Global, Revenue Forecasts ($mn), 2000-2008
Table 54: Multiple Sclerosis Therapeutics Market, Global, Revenue Forecasts ($mn), 2008-2015
Table 55: Multiple Sclerosis Therapeutics Market, Global, Average Cost of Therapy, 2000-2008
Table 56: Multiple Sclerosis Therapeutics Market, Global, Average Cost of Therapy, 2008-2015
Table 57: Multiple Sclerosis Therapeutics Market, Global, Volume, 2000-2008
Table 58: Multiple Sclerosis Therapeutics Market, Global, Volume, 2008-2015
Table 59: Multiple Sclerosis Therapeutics Market, Global, Diseased Population, 2000-2008
Table 60: Multiple Sclerosis Therapeutics Market, Global, Diseased Population, 2008-2015
Table 61: Multiple Sclerosis Therapeutics Market, Global, Volume, 2000-2008
Table 62: Multiple Sclerosis Therapeutics Market, Global, Volume, 2008-2015
Table 63: Multiple Sclerosis Therapeutics Market, Global, Diagnosis Population, 2000-2008
Table 64: Multiple Sclerosis Therapeutics Market, Global, Diagnosis Population, 2008-2015
Table 65: Multiple Sclerosis Therapeutics Market, Global, Prescription Population, 2000-2008
Table 66: Multiple Sclerosis Therapeutics Market, Global, Prescription Population, 2008-2015
Table 67: Multiple Sclerosis Therapeutics Market, Global, Therapeutics Usage Patterns, 2000-2008
Table 68: Multiple Sclerosis Therapeutics Market, Global, Therapeutics Usage Patterns, 2008-2015
Table 69: Multiple Sclerosis Therapeutics Market, Global, Major Manufacturers and Drugs, 2008
Table 70: Psoriasis Therapeutics Market, Global, Revenue Forecasts ($mn), 2000-2008
Table 71: Psoriasis Therapeutics Market, Global, Revenue Forecasts ($mn), 2008-2015
Table 72: Psoriasis Therapeutics Market, Global, Average Cost of Therapy, 2000-2008
Table 73: Psoriasis Therapeutics Market, Global, Average Cost of Therapy, 2008-2015
Table 74: Psoriasis Therapeutics Market, Global, Volume, 2000-2008
Table 75: Psoriasis Therapeutics Market, Global, Volume, 2008-2015
Table 76: Psoriasis Therapeutics Market, Global, Diseased Population, 2000-2008
Table 77: Psoriasis Therapeutics Market, Global, Diseased Population, 2008-2015
Table 78: Psoriasis Therapeutics Market, Global, Treatment Seeking Population, 2000-2008
Table 79: Psoriasis Therapeutics Market, Global, Treatment Seeking Population, 2008-2015
Table 80: Psoriasis Therapeutics Market, Global, Diagnosis Population, 2000-2008
Table 81: Psoriasis Therapeutics Market, Global, Diagnosis Population, 2008-2015
Table 82: Psoriasis Therapeutics Market, Global, Prescription Population, 2000-2008
Table 83: Psoriasis Therapeutics Market, Global, Prescription Population, 2008-2015
Table 84: Psoriasis Therapeutics Market, Global, Therapeutic Usage Patterns, 2000-2008
Table 85: Psoriasis Therapeutics Market, Global, Therapeutics Usage Patterns, 2008-2015
Table 86: Psoriasis Therapeutics Market, Global, Major Manufacturers and Drugs, 2008
Table 87: Crohn's Disease Therapeutics Market, Global, Revenue Forecasts ($mn), 2000-2008
Table 88: Crohn's Disease Therapeutics Market, Global, Revenue Forecasts ($mn), 2008-2015
Table 89: Crohn's Disease Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2008
Table 90: Crohn's Disease Therapeutics Market, Global, Average Cost of Therapy ($), 2008-2015
Table 91: Crohn's Disease Therapeutics Market, Global, Volume, 2000-2008
Table 92: Crohn's Disease Therapeutics Market, Global, Volume, 2008-2015
Table 93: Crohn's Disease Therapeutics Market, Global, Diseased Population, 2000-2008
Table 94: Crohn's Disease Therapeutics Market, Global, Diseased Population, 2008-2015
Table 95: Crohn's Disease Therapeutics Market, Global, Treatment Seeking Population, 2000-2008
Table 96: Crohn's Disease Therapeutics Market, Global, Treatment Seeking Population, 2008-2015
Table 97: Crohn's Disease Therapeutics Market, Global, Diagnosis Population, 2000-2008
Table 98: Crohn's Disease Therapeutics Market, Global, Diagnosis Population, 2008-2015
Table 99: Crohn's Disease Therapeutics Market, Global, Prescription Population, 2000-2008
Table 100: Crohn's Disease Therapeutics Market, Global, Prescription Population, 2008-2015
Table 101:Crohn's Disease Therapeutics Market, Global, Therapeutics Usage Patterns, 2000-2008
Table 102:Crohn's Disease Therapeutics Market, Global, Therapeutics Usage Patterns, 2008-2015
Table 103:Crohn's Disease Therapeutics Market, Global, Major Manufacturers and Drugs, 2008
Table 104:Ulcerative Colitis Therapeutics Market, Global, Revenue Forecasts ($mn), 2000-2008
Table 105:Ulcerative Colitis Therapeutics Market, Global, Revenue Forecasts ($mn), 2008-2015
Table 106:Ulcerative Colitis Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2008
Table 107: Ulcerative Colitis Therapeutics Market, Global, Average Cost of Therapy ($), 2008-2015
Table 108:Ulcerative Colitis Therapeutics Market, Global, Volume, 2000-2008
Table 109: Ulcerative Colitis Therapeutics Market, Global, Volume, 2008-2015
Table 110:Ulcerative Colitis Therapeutics Market, Global, Diseased Population, 2000-2008
Table 111:Ulcerative Colitis Therapeutics Market, Global, Diseased Population, 2008-2015
Table 112:Ulcerative Colitis Therapeutics Market, Global, Treatment Seeking Population, 2000-2008
Table 113:Ulcerative Colitis Therapeutics Market, Global, Treatment Seeking Population, 2008-2015
Table 114:Ulcerative Colitis Therapeutics Market, Global, Diagnosis Population, 2000-2008
Table 115:Ulcerative Colitis Therapeutics Market, Global, Diagnosis Population, 2008-2015
Table 116:Ulcerative Colitis Therapeutics Market, Global, Prescription Population, 2000-2008
Table 117:Ulcerative Colitis Therapeutics Market, Global, Prescription Population, 2008-2015
Table 118:Ulcerative Colitis Therapeutics Market, Global, Therapeutic Usage Patterns, 2000-2008
Table 119:Ulcerative Colitis Therapeutics Market, Global, Therapeutic Usage Patterns, Global, 2008-2015
Table 120:Ulcerative Colitis Therapeutics Market, Global, Major Manufacturers and Drugs, 2008
Table 121:Autoimmune Disease Therapeutics Market, US, Revenue Forecasts ($mn), 2000-2008
Table 122:Autoimmune Disease Therapeutics Market, US, Revenue Forecasts ($mn), 2008-2015
Table 123:Autoimmune Disease Therapeutics Market, US, Average Cost of Therapy ($), 2000-2008
Table 124:Autoimmune Disease Therapeutics Market, US, Average Cost of Therapy ($), 2008-2015
Table 125: Autoimmune Disease Therapeutics Market, US, Volume, 2000-2008
Table 126: Autoimmune Disease Therapeutics Market, US, Volume, 2008-2015
Table 127: Autoimmune Disease Therapeutics Market, US, Diseased Population, 2000-2008
Table 128: Autoimmune Disease Therapeutics Market, US, Diseased Population, 2008-2015
Table 129: Autoimmune Disease Therapeutics Market, US, Treatment Seeking Population, 2000-2008
Table 130: Autoimmune Disease Therapeutics Market, US, Treatment Seeking Population, 2008-2015
Table 131: Autoimmune Disease Therapeutics Market, US, Diagnosis Population, 2000-2008
Table 132: Autoimmune Disease Therapeutics Market, US, Diagnosis Population, 2008-2015
Table 133: Autoimmune Disease Therapeutics Market, US, Prescription Population, 2000-2008
Table 134: Autoimmune Disease Therapeutics Market, US, Prescription Population, 2008-2015
Table 135: Autoimmune Disease Therapeutics Market, US, Therapeutics Usage Patterns, 2000-2008
Table 136: Autoimmune Disease Therapeutics Market, US, Therapeutics Usage Patterns, 2008-2015
Table 137: Autoimmune Disease Therapeutics Market, Europe, Revenue Forecasts ($mn), 2000-2008
Table 138: Autoimmune Disease Therapeutics Market, Europe, Revenue Forecasts ($mn), 2008-2015
Table 139: Autoimmune Disease Therapeutics Market, Europe, Average Cost of Therapy ($), 2000-2008
Table 140: Autoimmune Disease Therapeutics Market, Europe, Average Cost of Therapy ($), 2008-2015
Table 141: Autoimmune Disease Therapeutics Market, Europe, Volume, 2000-2008
Table 142: Autoimmune Disease Therapeutics Market, Europe, Volume, 2008-2015
Table 143: Autoimmune Disease Therapeutics Market, Europe, Diseased Population, 2000-2008
Table 144: Autoimmune Disease Therapeutics Market, Europe, Diseased Population, 2008-2015
Table 145: Autoimmune Disease Therapeutics Market, Europe, Treatment Seeking Population, 2000-2008
Table 146: Autoimmune Disease Therapeutics Market, Europe, Treatment Seeking Population, 2008-2015
Table 147: Autoimmune Disease Therapeutics Market, Europe, Diagnosis Population, 2000-2008
Table 148: Autoimmune Disease Therapeutics Market, Europe, Diagnosis Population, 2008-2015
Table 149: Autoimmune Disease Therapeutics Market, Europe, Prescription Population, 2000-2008
Table 150: Autoimmune Disease Therapeutics Market, Europe, Prescription Population, 2008-2015
Table 151: Autoimmune Disease Therapeutics Market, Europe, Therapeutic Usage Patterns, 2000-2008
Table 152: Autoimmune Disease Therapeutics Market, Europe, Therapeutic Usage Patterns, 2008-2015
Table 153: Autoimmune Disease Therapeutics Market, Japan, Revenue Forecasts ($mn), 2000-2008
Table 154: Autoimmune Disease Therapeutics Market, Japan, Revenue Forecasts ($mn), 2000-2015
Table 155: Autoimmune Disease Therapeutics Market, Japan, Average Cost of Therapy, 2000-2008
Table 156: Autoimmune Disease Therapeutics Market, Japan, Average Cost of Therapy, 2008-2015
Table 157: Autoimmune Disease Therapeutics Market, Japan, Volume, 2000-2008
Table 158: Autoimmune Disease Therapeutics Market, Japan, Volume, 2008-2015
Table 159: Autoimmune Disease Therapeutics Market, Japan, Diseased Population, 2000-2008
Table 160: Autoimmune Disease Therapeutics Market, Japan, Diseased Population, 2008-2015
Table 161: Autoimmune Disease Therapeutics Market, Japan, Treatment Seeking Population, 2000-2008
Table 162: Autoimmune Disease Therapeutics Market, Japan, Treatment Seeking Population, 2008-2015
Table 163: Autoimmune Disease Therapeutics Market, Japan, Diagnosis Population, 2000-2008
Table 164: Autoimmune Disease Therapeutics Market, Japan, Diagnosis Population, 2008-2015
Table 165: Autoimmune Disease Therapeutics Market, Japan, Prescription Population, 2000-2008
Table 166: Autoimmune Disease Therapeutics Market, Japan, Prescription Population, 2008-2015
Table 167:Autoimmune Disease Therapeutics Market, Japan, Therapeutics Usage Patterns, 2000-2008
Table 168:Autoimmune Disease Therapeutics Market, Japan, Therapeutics Usage Patterns, 2008-2015
Table 169: Autoimmune Disease Therapeutics Market, Global, Licensing Agreements for Drugs in the Discovery and Preclinical Stages, 2008
Table 170: Autoimmune Disease Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase I Stage, 2008
Table 171: Autoimmune Disease Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase II Stage, 2008
Table 172: Autoimmune Disease Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase III Stage, 2008
Table 173: Autoimmune Disease Therapeutics Market, Global, Licensing Agreements for Drugs in the Approved Stage, 2008
1.2 List of Figures
Figure 1: Global Autoimmune Disease Therapeutics Market, Global Percentage Incidence of Autoimmune Diseases by Sex, 2008
Figure 2: Autoimmune Disease Therapeutics Market, Global, Major Factors Influencing the Market, 2008
Figure 3: Autoimmune Disease Therapeutics Market, Global, Key Geographical Trends, 2008
Figure 4: Autoimmune Disease Therapeutics Market, Global, Revenue Forecasts ($mn), 2000-2015
Figure 5: Autoimmune Disease Therapeutics Market, Global, Revenue Split ($bn), 2000-2015
Figure 6: Autoimmune Therapeutics Market, Global, Market Share of Disease Sectors, 2008
Figure 7: Autoimmune Disease Therapeutics Market, Global, Comparative Assessment of Key Autoimmune Disease Sectors, 2008
Figure 8: Autoimmune Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2015
Figure 9: Autoimmune Disease Therapeutics Market, Global, Volume, 2000-2015
Figure 10: Autoimmune Disease Therapeutics Market, Global, Diseased Population, 2000-2015
Figure 11: Autoimmune Disease Therapeutics Market, Global, Treatment Seeking Population, 2000-2015
Figure 12: Autoimmune Disease Therapeutics Market, Global, Diagnosis Population, 2000-2015
Figure 13: Autoimmune Disease Therapeutics Market, Global, Prescription Population, 2000-2015
Figure 14: Autoimmune Disease Therapeutics Market, Global, Therapeutics Usage Patterns, 2000-2015
Figure 15: Autoimmune Disease Therapeutics Market, Global, Geographical Distribution of Revenues ($mn), 2000-2015
Figure 16: Autoimmune Disease Therapeutics Market, Global, Market Indicators, 2008
Figure 17: Autoimmune Disease Therapeutics Market, Global, Analysis of Unmet Needs for Rheumatoid Arthritis Therapeutics, 2008
Figure 18: Autoimmune Disease Therapeutics Market, Global, Analysis of Unmet Needs for Rheumatoid Arthritis Therapeutics, 2008
Figure 19: Autoimmune Disease Therapeutics Market, Global, Analysis of Unmet Needs for SLE Therapeutics, 2008
Figure 20: Autoimmune Disease Therapeutics Market, Global, Analysis of Unmet Needs for Ulcerative Colitis Therapeutics, 2008
Figure 21: Autoimmune Disease Therapeutics Market, Global, Analysis of Unmet Needs for Crohn's Disease Therapeutics, 2008
Figure 22: Autoimmune Disease Therapeutics Market, Global, Analysis of Unmet Needs for Multiple Sclerosis Therapeutics, 2008
Figure 23: Autoimmune Disease Therapeutics Market, Global, Analysis of Unmet Needs for Psoriasis Therapeutics, 2008
Figure 24: Autoimmune Disease Therapeutics Market, Global, Correlation Between Growth in Prescription Population and Market Revenues, 2000-2015
Figure 25: Autoimmune Disease Therapeutics Market, Global, Comparative Analysis of Growth in Biologics Versus Chemotherapy, 2000-2015
Figure 26: Autoimmune Disease Therapeutics Market, Global, Assessment of Growth in Drug Label Extensions, 2000-2015
Figure 27: Autoimmune Disease Therapeutics Market, Global, Assessment of Growth in M&A and Licensing Agreements, 2008-2009
Figure 28: Rheumatoid Arthritis Therapeutics Market, Global, Revenue Forecasts ($mn), 2000-2015
Figure 29: Rheumatoid Arthritis Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2015
Figure 30: Rheumatoid Arthritis Therapeutics Market, Global, Volume, 2000-2015
Figure 31: Rheumatoid Arthritis Therapeutics Market, Global, Diseased Population, 2000-2015
Figure 32: Rheumatoid Arthritis Market, Global, Treatment Seeking Population, 2000-2015
Figure 33: Rheumatoid Arthritis Therapeutics Market, Global, Diagnosis Population, 2000-2008
Figure 34: Rheumatoid Arthritis Therapeutics Market, Global, Prescription Population, 2000-2015
Figure 35: Rheumatoid Arthritis Therapeutics Market, Global, Therapeutic Usage Patterns, 2000-2015
Figure 36: Rheumatoid Arthritis Therapeutics Market, Global, Market Share of Major Therapeutic Drugs, 2008
Figure 37: Rheumatoid Arthritis Therapeutics Market, Global, Revenue Forecasts of Major Drugs, 2006-2008
Figure 38: Rheumatoid Arthritis Therapeutics Market, Global, Assessment of Therapeutics Classes in Pipeline, 2008
Figure 39: Rheumatoid Arthritis Therapeutics Market, Global, Share Assessment of Molecules Under Stages of Development, 2008
Figure 40: Rheumatoid Arthritis Therapeutics Market, Global, Major Manufacturers and their Pipeline Portfolio, 2008
Figure 41: Systemic Lupus Erythematosus Therapeutics Market, Global, Revenue Forecasts ($mn), 2000-2015
Figure 42: Systemic Lupus Erythematosus Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2015
Figure 43: Systemic Lupus Erythematosus Therapeutics Market, Global, Volume, 2000-2015
Figure 44: Systemic Lupus Erythematosus Therapeutics Market, Global, Diseased Population, 2000-2015
Figure 45: Systemic Lupus Erythematosus Therapeutics Market, Global, the Treatment Seeking Population, 2000-2015
Figure 46: Systemic Lupus Erythematosus Therapeutics Market, Global, Diagnosis Population, 2000-2015
Figure 47: Systemic Lupus Erythematosus Therapeutics Market, Global, Prescription Population, 2000-2015
Figure 48: Systemic Lupus Erythematosus Therapeutics Market, Global, Therapeutics Usage Patterns, 2000-2015
Figure 49: Systemic Lupus Erythematosus Therapeutics Market, Global, Market Share of Major Therapeutics Drugs, 2008
Figure 50: Systemic Lupus Erythematosus Therapeutics Market, Global, Revenue Forecasts of Major Drugs, 2006-2008
Figure 51: Systemic Lupus Erythematosus Therapeutics Market, Global, Assessment of Therapeutics Classes in Pipeline, 2008
Figure 52: Systemic Lupus Erythematosus Therapeutics Market, Global, Share Assessment of Molecules Under Stages of Development, 2008
Figure 53: Systemic Lupus Erythematosus Therapeutics Market, Global, Major Manufacturers and their Pipeline Portfolio, 2008
Figure 54: Multiple Sclerosis Therapeutics Market, Global, Revenue Forecasts ($mn), 2000-2015
Figure 55: Multiple Sclerosis Therapeutics Market, Global, Average Cost of Therapy, 2000-2015
Figure 56: Multiple Sclerosis Therapeutics Market, Global, Volume, 2000-2015
Figure 57: Multiple Sclerosis Therapeutics Market, Global, Diseased Population, 2000-2015
Figure 58: Multiple Sclerosis Therapeutics Market, Global, Treatment Seeking Population, 2000-2015
Figure 59: Multiple Sclerosis Therapeutics Market, Global, Diagnosis Population, 2000-2015
Figure 60: Multiple Sclerosis Therapeutics Market, Global, Prescription Population, 2000-2015
Figure 61: Multiple Sclerosis Therapeutics Market, Global, Therapeutic Usage Patterns, 2000-2015
Figure 62: Multiple Sclerosis Therapeutics Market, Global, Market Share of Major Therapeutics Drugs, 2008
Figure 63: Multiple Sclerosis Therapeutics Market, Global, Revenue Forecasts of Major Drugs, 2006-2008
Figure 64: Multiple Sclerosis Therapeutics Market, Global, Assessment of Therapeutics Classes in Pipeline, 2008
Figure 65: Multiple Sclerosis Therapeutics Market, Global, Share Assessment of Molecules Under Stages of Development, 2008
Figure 66: Multiple Sclerosis Therapeutics Market, Global, Major Manufacturers and their Pipeline Portfolio, 2008
Figure 67: Psoriasis Therapeutics Market, Global, Revenue Forecasts ($mn), 2000-2015
Figure 68: Psoriasis Therapeutics Market, Global, Average Cost of Therapy, 2000-2015
Figure 69: Psoriasis Therapeutics Market, Global, Volume, 2000-2015
Figure 70: Psoriasis Therapeutics Market, Global, Diseased Population, 2000-2015
Figure 71: Psoriasis Therapeutics Market, Global, Treatment Seeking Population, 2000-2015
Figure 72: Psoriasis Therapeutics Market, Global, Diagnosis Population, 2000-2015
Figure 73: Psoriasis Therapeutics Market, Global, Prescription Population, 2000-2015
Figure 74: Psoriasis Therapeutics Market, Global, Therapeutic Usage Patterns, 2000-2015
Figure 75: Psoriasis Therapeutics Market, Global, Market Share of Major Therapeutics Drugs, 2008
Figure 76: Psoriasis Therapeutics Market, Global, Revenue Major Drugs, 2006-2008
Figure 77: Psoriasis Therapeutics Market, Global, Assessment of Therapeutics Classes in Pipeline, 2008
Figure 78: Psoriasis Therapeutics Market, Global, Share Assessment of Molecules Under Stages of Development, 2008
Figure 79: Psoriasis Therapeutics Market, Global, Major Manufacturers and their Pipeline Portfolio, 2008
Figure 80: Crohn's Disease Therapeutics Market, Global, Revenue Forecasts ($mn), 2000-2015
Figure 81: Crohn's Disease Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2015
Figure 82: Crohn's Disease Therapeutics Market, Global, Volume, 2000-2015
Figure 83: Crohn's Disease Therapeutics Market, Global, Disease Population, 2000-2015
Figure 84: Crohn's Disease Therapeutics Market, Global, Treatment Seeking Population, 2000-2015
Figure 85: Crohn's Disease Therapeutics Market, Global, Diagnosis Population, 2000-2015
Figure 86: Crohn's Disease Therapeutics Market, Global, Prescription Population, 2000-2015
Figure 87: Crohn's Disease Therapeutics Market, Global, Therapeutics Usage Patterns, 2000-2015
Figure 88: Crohn's Disease Therapeutics Market, Global, Market Share of Major Therapeutic Drugs, 2008
Figure 89: Crohn's Disease Therapeutics Market, Global, Revenue Major Drugs, 2006-2008
Figure 90: Crohn's Disease Therapeutics Market, Global, Assessment of Therapeutics Classes in Pipeline, 2008
Figure 91: Crohn's Disease Therapeutics Market, Global, Share Assessment of Molecules Under Stages of Development, 2008
Figure 92: Crohn's Disease Therapeutics Market, Global, Major Manufacturers and their Pipeline Portfolio, 2008
Figure 93: Ulcerative Colitis Therapeutics Market, Global, Revenue Forecasts ($mn), 2000-2015
Figure 94: Ulcerative Colitis Therapeutics Market, Global, Average Cost of Therapy ($), 2000-2015
Figure 95: Ulcerative Colitis Therapeutics Market, Global, Volume, 2000-2015
Figure 96: Ulcerative Colitis Therapeutics Market, Global, Diseased Population, 2000-2015
Figure 97: Ulcerative Colitis Therapeutics Market, Global, Treatment Seeking Population, 2000-2015
Figure 98: Ulcerative Colitis Therapeutics Market, Global, Diagnosis Population, 2000-2015
Figure 99: Ulcerative Colitis Therapeutics Market, Global, Prescription Population, 2000-2015
Figure 100:Ulcerative Colitis Therapeutics Market, Global, Therapeutics Usage Patterns, 2000-2015
Figure 101:Ulcerative Colitis Therapeutics Market, Global, Market Share of Major Therapeutic Drugs, 2008
Figure 102:Ulcerative Colitis Therapeutics Market, Global, Revenue Major Drugs, 2006-2008
Figure 103:Ulcerative Colitis Therapeutics Market, Global, Assessment of Therapeutics Classes in Pipeline, 2008
Figure 104:Ulcerative Colitis Therapeutics Market, Global, Assessment of
To order this report:
Pharmaceutical Industry: The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
More Market Research Report
Nicolas Bombourg Reportlinker Email: [email protected] US: (805)-652-2626 Intl: +1 805-652-2626
SOURCE Reportlinker
